SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as investors weigh concerns over share dilution and a persistent decline in stock price against optimism regarding the accelerating commercial rollout of its fibromyalgia drug, TONMYA. Community sentiment remains highly polarized, with active debates centered on whether recent institutional interest and prescription growth signal an undervalued asset ready for a rebound or if historical management patterns suggest further downside.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as investors react to a strengthened balance sheet following a completed pension reversion and ongoing strategic pivots into pharmaceutical API manufacturing and advanced materials. The community is actively speculating on potential government contracts and national security partnerships, with shareholders closely monitoring corporate developments for catalysts that could trigger a significant revaluation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is surging as the community celebrates the departure of a high-profile FDA official, a move investors widely view as removing a major regulatory roadblock for the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. Traders are actively buzzing about this leadership shift and anticipating critical late-breaking Phase 3 data presentations, which are fueling heavy bullish sentiment and speculation of a near-term path to market.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors weigh its significant recovery progress, including recent debt reduction and restored NASDAQ compliance, against a contentious short report that has triggered intense debate over the firm's asset valuation. While some community members view the stock as a prime short-squeeze candidate with deep value potential, others remain cautious due to ongoing legal disputes and the lingering uncertainty surrounding pending financial filings.

Foley Trasimene Acquisition Corp. II operates as a blank check company. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by William Patrick Foley II on July 15, 2020 and is headquartered in Las Vegas, NV.

Paysafe Limited

Paysafe Limited is facing heavy selling pressure and negative investor sentiment, driven by concerns over its debt load and a history of missed earnings guidance. While some market participants monitor the stock for potential accumulation or a turnaround, the broader community remains polarized, with many labeling it a struggling SPAC while others speculate on future buyout or privatization scenarios.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is currently trending as investors brace for the latest fiscal results, with the community closely tracking the company's QNX revenue performance and backlog growth as critical indicators of future scalability. While some participants express frustration over prolonged stagnant price action, many remain focused on potential institutional accumulation and the long-term impact of new automotive partnerships in the software-defined vehicle sector.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and community buzz as traders track whale accumulation and strategic infrastructure moves, including international expansion and anticipation of the Goliath mainnet launch. While some investors remain cautious of historical price patterns, many are closely watching key technical levels for a potential breakout as the project builds out its real-world asset and payment rail ecosystem.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is capturing investor attention following a report of its first-ever quarterly profit, which has sparked a wave of analyst upgrades and intense debate over its long-term growth versus ongoing share dilution. While retail shareholders are actively cheering the milestone as a potential turning point for the stock, the community remains divided between those calling for a squeeze and skeptics pointing to historically sluggish price action and institutional resistance.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant market volatility as investors weigh strong earnings and consistent revenue growth against the immediate uncertainty of a pending CEO transition. The community remains deeply divided, with some betting on a rebound fueled by AI-driven ARR growth, while others express skepticism regarding the company's long-term competitive moat against emerging AI alternatives.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

UUP is trending as investors grapple with shifting Fed rate-cut expectations amid persistent trade uncertainty and ongoing geopolitical tensions. The community is heavily focused on the dollar's strength relative to precious metals and risk assets, debating whether current price action signals a lasting rebound or further debasement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by GW&K Investment Management LLC

GW&K Investment Management LLC decreased its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 16.2% in the 3rd quarter, according to its most recent Form 13F filing...

BioCryst Pharmaceuticals Conference: Profitability Pivot, ORLADEYO Growth, Navenibart Phase 3 Timeline

BioCryst Pharmaceuticals (NASDAQ:BCRX) executives highlighted the company's transition to profitability, continued growth of its hereditary angioedema (HAE) franchise, and progress on newly acquired...

BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC cut its stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 5.4% in the third quarter, according to the company in its most recent disclosure with the...

BioCryst Pharmaceuticals, Inc. $BCRX Stock Holdings Boosted by Vanguard Group Inc.

Vanguard Group Inc. lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 6.1% during the third quarter, according to its most recent 13F filing with the SEC. The...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 10.7% After Earnings Beat

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading 10.7% Higher on Better-Than-Expected Earnings...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen analysts that are presently covering the stock...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Posts Quarterly Earnings Results, Beats Expectations By $1.05 EPS

BioCryst Pharmaceuticals (NASDAQ:BCRX - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $1.12 earnings per share (EPS) for the quarter, beating...

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of +1,623.08% and +172.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BioCryst Pharmaceuticals Q4 Earnings Call Highlights

BioCryst Pharmaceuticals (NASDAQ:BCRX) outlined its full-year 2025 performance and priorities for 2026 during its fourth-quarter conference call, highlighting strong growth for its hereditary...

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up After Better-Than-Expected Earnings

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Up on Strong Earnings...

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Current Price	$8.49
Prev Close	$8.75
Open	$8.69
Dividend Yield	0.00%
50-Day Moving Average	$7.33
Beta	0.89
Avg. Volume	4.48M
PE Ratio	7.06

52-Week High	$11.31
52-Week Low	$6.00
Market Capitalization	$2.13B
EPS (Annual)	$1.21
Price to Book	-15.18
Revenue Per Employee	$2.01M

BCRX
Biocryst Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCRX News

BCRXBiocryst Pharmaceuticals Inc.